These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12210556)

  • 1. Anti-tumor mechanisms of valproate: a novel role for an old drug.
    Blaheta RA; Cinatl J
    Med Res Rev; 2002 Sep; 22(5):492-511. PubMed ID: 12210556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells.
    Castro LM; Gallant M; Niles LP
    J Neurochem; 2005 Dec; 95(5):1227-36. PubMed ID: 16313512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells.
    Greenblatt DY; Vaccaro AM; Jaskula-Sztul R; Ning L; Haymart M; Kunnimalaiyaan M; Chen H
    Oncologist; 2007 Aug; 12(8):942-51. PubMed ID: 17766653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition.
    Michaelis M; Suhan T; Reinisch A; Reisenauer A; Fleckenstein C; Eikel D; Gümbel H; Doerr HW; Nau H; Cinatl J
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3451-7. PubMed ID: 16123451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
    Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
    Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of peroxisome proliferator-activated receptor delta activity affects neural cell adhesion molecule and polysialyltransferase ST8SiaIV induction by teratogenic valproic acid analogs in F9 cell differentiation.
    Lampen A; Grimaldi PA; Nau H
    Mol Pharmacol; 2005 Jul; 68(1):193-203. PubMed ID: 15829700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation.
    Sinn DI; Kim SJ; Chu K; Jung KH; Lee ST; Song EC; Kim JM; Park DK; Kun Lee S; Kim M; Roh JK
    Neurobiol Dis; 2007 May; 26(2):464-72. PubMed ID: 17398106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.
    Neri P; Tagliaferri P; Di Martino MT; Calimeri T; Amodio N; Bulotta A; Ventura M; Eramo PO; Viscomi C; Arbitrio M; Rossi M; Caraglia M; Munshi NC; Anderson KC; Tassone P
    Br J Haematol; 2008 Nov; 143(4):520-31. PubMed ID: 18986388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line.
    Farrelly LA; Savage NT; O'Callaghan C; Toulouse A; Yilmazer-Hanke DM
    Regul Pept; 2013 Sep; 186():123-30. PubMed ID: 23994577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium valproate at therapeutic concentrations changes Ca2+ response accompanied with its weak inhibition of protein kinase C in human astrocytoma cells.
    Kurita M; Nishino S; Ohtomo K; Rai M; Shirakawa H; Mashiko H; Niwa S; Nakahata N
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):600-4. PubMed ID: 17258372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
    Cho HH; Park HT; Kim YJ; Bae YC; Suh KT; Jung JS
    J Cell Biochem; 2005 Oct; 96(3):533-42. PubMed ID: 16088945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases.
    Göttlicher M
    Ann Hematol; 2004; 83 Suppl 1():S91-2. PubMed ID: 15124690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; Iñiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives.
    Eikel D; Lampen A; Nau H
    Chem Res Toxicol; 2006 Feb; 19(2):272-8. PubMed ID: 16485903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes.
    Milutinovic S; D'Alessio AC; Detich N; Szyf M
    Carcinogenesis; 2007 Mar; 28(3):560-71. PubMed ID: 17012225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of c-Myc is critical for valproic acid-induced growth arrest and myeloid differentiation of acute myeloid leukemia.
    Cheng YC; Lin H; Huang MJ; Chow JM; Lin S; Liu HE
    Leuk Res; 2007 Oct; 31(10):1403-11. PubMed ID: 17445886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions.
    Fukuchi M; Nii T; Ishimaru N; Minamino A; Hara D; Takasaki I; Tabuchi A; Tsuda M
    Neurosci Res; 2009 Sep; 65(1):35-43. PubMed ID: 19463867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
    Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
    Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
    Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.